Last news
Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA

Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA

SINGAPORE, Oct. 26, 2023 /PRNewswire/ -- On October 26, 2023, Biosyngen's TIL therapy BST02 for liver cancer was granted an approval for clinical trial by the US FDA. BST02, a breakthrough product in the field of cell and gene therapy, represents...

Discover the Enchanting World of Chinese Life Aesthetics through Daily Ceramics at the 134th Canton Fair

Discover the Enchanting World of Chinese Life Aesthetics through Daily Ceramics at the 134th Canton Fair

GUANGZHOU, China, Oct. 26, 2023 /PRNewswire/ -- The onsite exhibition of 134th China Import and Export Fair("Canton Fair" or "the Fair") embarks on its second phase, transforming the exhibition grounds into a mesmerizing realm of trade and cultural...

YOFC Showcases Optical Communication Innovations at SCTE CABLE-TEC EXPO® 2023

YOFC Showcases Optical Communication Innovations at SCTE CABLE-TEC EXPO® 2023

DENVER, Oct. 26, 2023 /PRNewswire/ -- Yangtze Optical Fibre and Cable Joint stock Limited Company (YOFC) showcased its advanced optical fibres, new optical cable variants, high-density data center solutions, and streamlined F.ODN pre-connected...

Appian Launches Connected Underwriting for Life Insurance in Partnership with Swiss Re

Appian Launches Connected Underwriting for Life Insurance in Partnership with Swiss Re

New workbench enables holistic underwriting automation and workload management to improve operational efficiency and underwriter experience. MCLEAN, Va., Oct. 26, 2023 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced the availability of the...

Torbjörn Lööf proposed as new Chairman of AB Electrolux

Torbjörn Lööf proposed as new Chairman of AB Electrolux

The Nomination Committee of AB Electrolux proposes that Torbjörn Lööf is elected as new Chairman of the Board of AB Electrolux at the Annual General Meeting 2024. STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- As previously communicated, Staffan Bohman...

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

JINAN, China, Oct. 25, 2023 /PRNewswire/ -- On October 22, Qilu Pharmaceutical unveiled the latest findings from a multicenter, single-arm Phase II clinical trial at the European Society for Medical Oncology (ESMO) Annual Congress 2023. This trial...

Trip.com Group Empowers the Travel Industry with Transformative AI Innovation

Trip.com Group Empowers the Travel Industry with Transformative AI Innovation

SINGAPORE, Oct. 25, 2023 /PRNewswire/ -- Trip.com Group, a global leader in online travel services, took centre stage at ITB Asia in Singapore, highlighting the pivotal role of Artificial Intelligence (AI) in reshaping the travel industry. James...

SK hynix's LPDDR5T, World's Fastest Mobile DRAM, Completes Compatibility Validation with Qualcomm

SK hynix's LPDDR5T, World's Fastest Mobile DRAM, Completes Compatibility Validation with Qualcomm

9.6Gbps product verified to be compatible with Qualcomm's new Snapdragon mobile processor With validation with global major partners completed, SK hynix to provide LPDDR5T to global smartphone customers "SK hynix, Qualcomm to collaborate further to...

1 ... 139 140 141 142 143 144 145 146 147 ... 1190
menu
menu